A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
Explore this paper's citation graph
- Type
- article
- Published
- 1996-11-16
- Cited by
- 2,802
- References
- 0
- OpenAlex
- https://openalex.org/W2529190803
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:78185529
Keywords
Clopidogrel, Medicine, Aspirin, Ticlopidine, Internal medicine
References
No references recorded for this paper.
Cited by
- Risk Factors and Event Rates in Patients With Atherothrombotic Disease in Germany: Results of the REACH Registry.
- Diabetes, Herzchirurgie und periphere Gefäße
- Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis
- Current Management of Peripheral Arterial Occlusive Disease
- Pathophysiology and clinical significance of atherosclerotic plaque rupture.
- Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention
- Current concepts in secondary prevention after acute myocardial infarction
- Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.
- Current Oral Antiplatelet Agents to Prevent Atherothrombosis
- Current Treatment and Future Prospects for the Management of Acute Coronary Syndromes
- Antiplatelet Therapies in Combination for the Treatment of Patients with Stable and Unstable Coronary Artery Disease
- Aspirin resistance: a new independent predictor of vascular events?
- Old and new cardiovascular risk factors: from unresolved issues to new opportunities.
- Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
- Effect of clopidogrel on tissue-plasminogen activator-induced in vitro thrombolysis of feline whole blood thrombi.
- Medical treatment of peripheral arterial disease: a comprehensive review.
- Is the Measurement of Cerebral Microembolic Signals a Good Surrogate Marker for Evaluating the Efficacy of Antiplatelet Agents in the Prevention of Stroke?
- Drug-Induced Thrombotic Microangiopathy
- Thrombelastography: Current clinical applications and its potential role in interventional cardiology
- Ticlopidine prevents the formation but delays the healing of ethanol-induced gastric lesions in the rat.
Related papers
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
- A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.
- Prasugrel versus clopidogrel in patients with acute coronary syndromes.
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
- Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
- Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
- Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.